DexCom Inc (DXCM)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 60.41% | 61.68% | 62.74% | 62.82% | 63.19% | 63.87% | 63.94% | 64.44% | 64.72% | 64.97% | 66.10% | 67.44% | 68.63% | 69.29% | 69.15% | 67.48% | 66.44% | 65.38% | 63.92% | 63.68% |
| Operating profit margin | 14.88% | 15.88% | 17.32% | 17.14% | 16.50% | 14.88% | 14.02% | 13.14% | 13.44% | 9.54% | 8.87% | 10.15% | 10.86% | 15.92% | 15.90% | 15.39% | 15.54% | 16.31% | 15.09% | 11.89% |
| Pretax margin | 17.58% | 18.81% | 20.51% | 20.47% | 19.61% | 17.56% | 15.74% | 13.87% | 13.43% | 8.70% | 7.01% | 7.34% | 7.10% | 11.64% | 11.72% | 11.04% | 11.68% | 13.07% | 12.16% | 9.57% |
| Net profit margin | 14.29% | 17.22% | 16.95% | 16.82% | 14.95% | 11.08% | 11.18% | 9.68% | 11.73% | 8.24% | 7.47% | 8.23% | 6.32% | 22.82% | 24.45% | 25.36% | 25.62% | 12.69% | 11.93% | 9.24% |
DexCom Inc's profitability ratios have displayed fluctuating trends over the past few years.
1. Gross Profit Margin: The company's gross profit margin has seen a slight decline from 63.68% in March 2020 to 60.41% in December 2024. This indicates that DexCom's ability to generate profit from its core operations has slightly decreased over the period.
2. Operating Profit Margin: DexCom's operating profit margin initially increased from 11.89% in March 2020 to 17.32% in June 2024, showing improved operational efficiency. However, there was a slight dip in the margin by December 2024 to 14.88%. This suggests that the company may have experienced some challenges in controlling its operating expenses.
3. Pretax Margin: The pretax margin fluctuated significantly, with a notable increase from 9.57% in March 2020 to 20.51% in June 2024. This indicates that DexCom was able to improve its profitability before accounting for taxes, likely due to increased revenue or cost management initiatives.
4. Net Profit Margin: The net profit margin also fluctuated, with an initial increase from 9.24% in March 2020 to 17.22% in September 2024. This suggests that DexCom was able to increase its profitability after accounting for all expenses including interest and taxes.
In summary, while DexCom Inc's profitability ratios have shown some variability, the company has demonstrated an overall ability to maintain healthy levels of profitability despite facing challenges in certain periods.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 9.25% | 9.88% | 10.02% | 10.05% | 9.54% | 7.67% | 6.57% | 7.20% | 7.26% | 5.44% | 4.55% | 5.17% | 5.47% | 7.73% | 7.66% | 7.10% | 6.98% | 7.75% | 7.35% | 7.77% |
| Return on assets (ROA) | 8.89% | 10.71% | 9.81% | 9.86% | 8.64% | 5.72% | 5.24% | 5.30% | 6.33% | 4.69% | 3.83% | 4.19% | 3.18% | 11.08% | 11.78% | 11.71% | 11.50% | 6.03% | 5.81% | 6.04% |
| Return on total capital | 33.24% | 38.55% | 33.94% | 35.55% | 35.32% | 27.23% | 24.90% | 19.61% | 19.20% | 15.46% | 11.06% | 12.40% | 12.29% | 17.42% | 17.69% | 16.70% | 16.96% | 20.90% | 20.30% | 22.90% |
| Return on equity (ROE) | 27.40% | 34.40% | 27.40% | 28.45% | 26.18% | 16.62% | 17.02% | 13.10% | 16.01% | 12.61% | 8.85% | 9.67% | 6.87% | 24.78% | 26.56% | 27.01% | 27.02% | 15.41% | 15.12% | 15.83% |
DexCom Inc's profitability ratios show varying trends over the reported periods.
The Operating Return on Assets (Operating ROA) fluctuated between 5.17% to 10.05% during the period, with a slight decrease towards the end of the period. This ratio indicates the company's ability to generate operating profits from its assets.
The Return on Assets (ROA) also had fluctuations, ranging from 3.18% to 11.78%, showing significant variability. The ratio peaked in June 2024, signifying strong profitability relative to the company's total assets.
The Return on Total Capital experienced a substantial increase from 11.06% in June 2022 to 38.55% in September 2024, suggesting improved efficiency in generating returns from both equity and debt capital.
The Return on Equity (ROE) displayed a similar pattern to ROA, with fluctuations from 6.87% to 34.40% over the reported periods. This ratio reflects the company's ability to generate profits for its shareholders from their equity investments.
Overall, DexCom Inc has shown varying profitability levels over the analyzed periods, with fluctuations across different profitability ratios. The company's ability to generate returns for both its assets and capital has shown improvement, as seen in the higher returns reported in the later periods.